Modular Medical, Inc.: Form 10-Q for the period ended Jun 30, 2020
Filed with the SEC on Aug 12, 2020 and accepted by EDGAR at Aug 12, 2020, 16:41 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2020-04-01 to 2020-06-30 | $970.8k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2020-04-01 to 2020-06-30 | −$1.9m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2020-04-01 to 2020-06-30 | −$1.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-04-01 to 2020-06-30 | −$0.10 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 3 months2020-04-01 to 2020-06-30 | −$1.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2020-04-01 to 2020-06-30 | $12.9k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2020-06-30 | $3.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-06-30 | $3.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-06-30 | $3.8m | us-gaap:Assets |
| Current liabilities | At period end2020-06-30 | $727.9k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-06-30 | $1.4m | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-06-30 | $2.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001019056-20-000470. Last ingested by Listed: Nov 11, 2026, 02:48 ET. Listed shows no prices and gives no investment advice.